Dexcom (DXCM) Return on Invested Capital (2012 - 2026)

Dexcom (DXCM) has 13 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Invested Capital changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.0% in Q1 2026 per DXCM's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2026 and bottomed at 0.0% in Q2 2022.
• The 5-year median for Return on Invested Capital is 0.0% (2023), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Tracing DXCM's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then climbed by 22 bps to 0.0% in 2023, then increased by 14 bps to 0.0% in 2024, then advanced by 7 bps to 0.0% in 2025, then climbed by 9 bps to 0.0% in 2026.
• Per Business Quant, the three latest DXCM Return on Invested Capital figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison